Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Explore well-known S&P 500 index funds for retirement 2024, focusing on performance, costs, and suitability for your plan.
22,695 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Job seekers are facing increasingly convincing thieves using AI to mimic recruiters and fake interview portals. Exper...
Investors woke up to a move in Comcast shares after strategic news and improving fundamentals. This article breaks do...
The FBI director disclosed a late Strategy stock purchase, prompting questions about STOCK Act timing and potential c...
MediaFuse launches TechnologyWire to broaden its distribution reach from crypto into the wider technology sector, lev...
Trinidad and Tobago signed two memorandums of understanding with U.S. firms to move forward with large-scale data cen...
A controversial proposal has sparked a fierce debate among developers, miners, and industry leaders. This article unp...
Money troubles can hit anyone, even a former star le’veon bell. This article digs into what happened, why it matters ...
Looking for a way into your first rental without draining cash reserves? A well-structured seller financing deal can ...
A large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
Nvidia delivers a standout quarter powered by AI demand, surpassing estimates and lifting guidance. This article brea...
Portillo's has faced growth and branding challenges that threaten its future. This guide breaks down what a comeback ...